: *
!"#
.
%&
' ( )
!
IL1β" # $% &
IL-665 - 50
) * +&, - . *
* 1 2
2
! " # 3
4
1 - ! "
"
# # $ # $ %&
.
2 - % ! "
"
# # $ # $ %&
.
3 - % * ! "
"
# # $ # $ %&
.
4 - % % *
# #%, #%, - ! %& .%/!
.
!
/ #
$
% / #
2 / '( ) 96
/ ,' ' 72
: 8 / 1 / 96 :
6 / 3 / 96
!%&!
:
(! ) *+ (! , +! - % " ./ 01 2!
3 4! 04 ! 56 .7 8 9 % 4:
. 4 <4 &=> "4/ ) ?%47
/ @A B C +! D%: ) 7 "/ > E ! FG 3 IL1β
4H) 04 ! B IL-6 65
- 50 4 - % 4 4 @+4M!
! , +!
%:
.
N 9 ! 7
:
24 , +! - % @+M! ) O
> "/ 9 H M O 9
%H9 8 P8 : < &=
. H9 !)Q 7 O E 4G 9 4 19 >
12 E H
%H%: 5 #&> R + 8 "/ >
. ) 7 / > ! H ,/ 9 "/ > E G 12
+ 7
# S + 7 7 8
# S 7 4 (! 4:
%H9 8 P8 : 9 P + P 9 / > P .
/ > P !) D%! %+ 9 8
8 9 & U9 4 & U9 ,/ + 7 7 %: V
D%!
!) P / > 7
! E9 01
%:
. 9 / >
W 0 ! B )
E) %H G
0 ! B G
IL-6 4 (4MUIL1β
P1 G - 6H %X E ! .
/06>
E9 9 ( =>
%/9 G E9 + + S > (&+#! > !Q N ) 7 .
+1 / 7 :
) 7 "/ > E ! ) YA 0 ! B
>
X!
9 ZH 9
%H . 0 ! IL-6 4 X! .7 48 "/ 4 > 43 9IL1β
9 / %4 +1
) 05 / 0
˂ (P .
6 +H ^=
G :
"/
+1 / 7 _H E% 79 3`>
-%4 4*+ (! .7 8 C +! D%: ) 7 "/ > E ! 3`4>
4
! 0 ! B
%:
. aS ! :) "/ > D%: !) (/%X> 8 9 9 9 S R + "/ 8F! b/ +H S >
3`>
B 4 E) %4H 4
99 G 0 ! .
Ec
% 8 7 :
) 7 "/ >
IL1β , +! - % 0 ! B IL-6
.
/
6196
!%&!
% :=* >
;= 3 = ?%=2 @ A= % 7 B=*
29 C DE .%$ % =7
= ) 1 ( . %=
;= ;=H
;=I7%H A= % 7 B=* J AK* L
"* 7
) 2 ( . M@ ; A % 7 B*
NO @ 3 N7%!
5 N7%!
7 Q3R 5E .
N7 ! :
2 S B %K!
94 %=*
= 7 =
U%== ==V 150
X5==*
HDL-C
== 2 40
V Y %9 2
)
110 (
# E % U%=
85 / 130 7 H 7 ) 2,3 ( . =2$7 >=] = S " %
A= % 7 B* *%B " ! .
A=
A=
=7
4 57 > = %= A= ^%=K A= % 7 B=*
: % %==*
%==$ > ==- %==9 )
2 ( . == S "== %
==_ A== # ==`29
#
==
: % %==* Y a ;==
7 X : % %*
;= =7 := =2 N=2! =B
8 <
7 _ b ] V X5=*
)IL-6 Interleukin 6
( 01=
7 c ) 6 - 4 ( . # `29 %$ N7 ! K! " %OIL-6
E * )
7 ( . %=$ N=7 ! 7 %= 7 =R
f = 7 = N=7%! #% > H gH 7 =7 L7 =
. )BDNF Brain-Derived Neurotrophic
Factor
( ;== "==* == N==7%!
h%==] g==H 7
N
7 #
= ) 8,9 (.
> = #%=
===
IL-6 TNF-a
)
Tumor Necrosis Factor
alpha
( g i ? =*
%=9 =7 > = = =9
) 8,10 ( > = E f ]j # % 29 % % : B`29
4 5==*
TNF-a
)IL1β Interleukin-1 beta
( ? ==*
#%= >9% gH 7 ; % 7 Y 9 BDNF
% k=7
7 2 l )
9 ( . : ]]j7 m 01=
"=Km7
=2 l = A= % 7 B=* l =
) 11 ( .
01 9%
1 =7 # =E = =]7 = l =
7 : ]]j7
% . : B`29 A 7
# % 29
;I %57
n == I7 ^%==K
==BI7 ==
l == BDNF
2 ) 12 ( . # =E = :7 7 >
# E %=
= o %=7 =E A= % 7 B=* ;= 3 =K7 # %2
; 9 E
;, %= ;= =H ?%2 @ :
#%== >9%==
;== % >9%== == ==L7 b==,@ BDNF
;, E%B= = 2! >9%= ; ,B7 =
) 13 ( .
p=j =7 Nq%V7 L7 b,@ >9% H 7 C i7 ! S %
=0 =L7 b=,@ >9%= ;=
== 2! ?3 ==E ;== ==,B7 A== % 7 B==* %==2 7 E%B )
2 ( . =* f ]j : r 9 01=
> =- N=7 ! = 6=* 7 8 = %= 9 : 2 %, 7 L7 4 5* %$
% . f= ]j : 01=
%=
! 01 =L7 4 5* 6* 7 8 % 9 l
O * 7
% 7 bV
%9 0s7 L7 b,@
=9 E =O =* "=j .
f= ]j =BS t %=
#%= >9%= : = 6 H #% % B
BDNF
B=* ;= 3 =K7 = %=$ > - N7 ! >
7 A % 7 =2 = S > ; %H %
# =E V # E %=
X5=* >9%=
HDL-C
>9%= % %=$ N=7 ! > = BDNF
7 ^%K =L7 4 5=* * " *%V@ %
7 % bV % 7
%9 = : #a N E .
% 8%] ]j # B % 01
# = 7 = = : =2
O * 7 %$ N7 ! =
. =] ]j =
;==
01==
4 5==* == 6==* 7 8 == %== ==9 l
! %2*3- #%=7 29 L7 4 5* %$ N7
H 9 O * 7 .
uB =* ?%=m7 =5
==
;==I %57 # %== 29 : ==2 %==7 ;==* u==-
L v 9 7%] * BI7
X5=* # 7
7 *
IL-6 hs-CRP
9% 7 .
# 7 ; K
TNF
=BI7 _ >9%
"=
) 14 ( . ;=I %57 =&
# %== 29 : ==VB V : ==2 %==7 ;==* u==- ==
%=$ N=7 ! # = 7 = L v =9 7%] *
IL-6
9% 7 )
15 ( . # % 29 ;=I %57
= L
BI7 : =2 %7 ;* u- %$ N7 ! # 7
== 9%== 7 7%] ==*
) 16 ( . ==* N== %]7
: 2 # % 29 0s=7
= .%=$ >9%=
B V A % 7 B* ; 3 K7 )
17 (.
=& r =R
=& 8%I %57 E >9%=
hs-CRP
l = IL-6
==2
==
.
# %== 29 # ==V "== ! ==E f== ]j
R L7 a 2
j ! ?%*
%=7a >9% w
= 2 #%= VDB K O )
18 ( . 2 =7 # %= 29
; 2 % 40
; D9
% - v 9
01 b=,@
" :V7 L7 )
19 ( . #%= # %= 29 # V
; 8 % % ;* ; D9 9 9 : 2 ?%* A
7 L7 b,@ > gH 7 6* 7 )
18 ( . ;=H %
=B 2 = 7 8 %=D ; = c 8%] ]j t % xO%B ; y%@ f ]j % 8 7 8 z%j { 8%] ]j ; c 8%] ]j # K o7%H 8 %=D
=7 a %=9
7
# = %= J = f ]j : ; 2 %
7
% . ; f ]j : ; S 01
! 01 12 ; D9
%=$ N=7 ! # 7 6* 7 8 % 9 : 2 #% L7 4 5*
60 - 50 A= % 7 B* ; 3 K7 ?%*
"E - 9 E .
9 ! N
7
* J , ;2 * l %= %9
7 u=- # =7 a > =- N7%= = 9 |- 4 =R ; %
, A 9% A % # 7 a .
!Q X! S
$== # ==V29 >9 |==- %==7a ;==I7%H 50
%==
65
; %*
= #%=, #% * $ A % 7 B* ; 3 K7 .
==$ a >==i- u==- ==7 $== %== B N==
#%==, #% ==* # %==m f== ]j %==_a
==I 30
#
$ g R ?%V % 7 #%,
) 50 %=
65 ; %=*
( c=E =
>9 |=- =} 7 %2VH " %I M@ ,7 6=*
@ %= %=2 f =* z%j A - %2=VH %=9
# E % . E E%B 83 7 I7
= ;=B %
N=2! ;= g= O "73* "V %$ a E % 8 <
7a . 7 a A v 9 ;] %* ; c ?%* A R %9
B b}B7 " %I "
. "=* = { ;= U
w3=7 f= ]j := ;
ATPIII
)
Adult Treatment
Panel III
( ~E%= %=*%B = % 7 =5E %=9
A
; %D * ;
;* M@
tB=- =7 :=
) =2
>
94
%*
= 7 =V
# =E =
>
150
7
* 2 # EHDL
40 7 =
* # E %=
> = 85 / 130 = 7 = 7 H =
U% % % # E 110
7
* (
B=* ;= 3 =K7 ~i= # =B! ;= =} 7 z%j A % 7 )
3 ( . g= R = & #% ;
# == 8 ==<
;==* > == %== ;==*
==5E ~E%==
w37 n%* A % 7
ATPIII
7 a # B! ;
z%j A % 7 B*
. ;= "* { ; U %=$S
7 a D
; %9 8%=B 2 b}B=7 M@ ! N
D u=- M@ ! N ; ? B
# 7 a t %= #%= %- = • %E f ]j #% H 24
D %7a N j ; ,
" O * 7 .
w3=7
= ;=V H ;V H ;* > "K _ • E .
U { ; b A - ~ i % ; "*
=7 a %=9
v 9 9 N=KO %7 > f ]j 8 7
r /7 #a .
/ > (Z> A
= ; ^ 7 8%B 2 : =2
) (ME
N7%=
; D9 N7% ; D9 9 ; 3
9 8 =7 ;=
24 %=
57 B I7 #%7 ;] O )
9 % 12 XK=<
( ) 20 ( %=
8 60 % 70 E{ g O #% y <
%, .
; =<% %= = 7 "=* ;=* g %O 8%B 2 ;V H 9 "@ * 5
: ;] O
"*
%9 =7 %=, =
. #%=7
/
6396
"*
;=] O "= 9 ? ;= D9 =B 2 %9 %= =
8 7 ; ;] O A ; D9 9 # Y*
#%7
"*
%=9
7 : 2
= ;=
=R b=9 ;= D9 ;=
"* ;* ; : 2 19
;] O
* . "=* = { ; U
7 AS ; D9 9 @ * g O #% y ; 8 = =
tB=* #% y %& * %D * % #a : 2 ;7%
3- )
Polar: Finland
( 7 b }B .
=2 8%V H N :
% 5 ;] O # =
) 7 = = 8%=B 2 >
( %=_a
7 #% %- 5
* ;] O "= =H # =
.
? B 8 7 :
; D9 %,
%I =
"
_ .%B H b}B7 ? 2I7 .
W G
7 a %2 %9
N7% ; @ 7 # =7 a > =-
u-
# 7 a ) I : =2 ; D9
( =E
# ;= =
"!%* % % 8 <
9 XK<
) =
4 5=*
%2*3- %$ N7 !
7 * = = =V
?%&S - : € - Y
%2*3- ( N2! ; =7a . ;= U ;= K
7 { rc=@ "=$H % 8 01=
l %=@
;= 2H
&
E1 g *a
%9 % E%* AS %2 @
M!
# = 7 ;
IL1β
u=- ;= @ 7 & =EIL-6
: Ea u- %$S # 7 a
;V H %, B 2
) 8,21 ( .
# E % 9
; 2 i =E %=9
) 2
*
* (
• 9% *
% . y %7 %@ %9
%]I o2HEDTA
a D %=* u=- = )
12
;] O
% 3000
;] O (
%2*3- %* H 4 5=*
%2*3- 6* IL1β
=
"
=]7 >,B=* |=
IL1β
)
eBioscience, Vienna, Austria
( " =*%V@ %=
pg/mL
05 / 0 6==* IL-6
==]7 >,B==* |== "==
IL-6
)
eBioscience, Vienna, Austria
( " ==*%V@ %==
pg/ml
03 / 0 U l ; .
=V = l ; # E ]7 4 5=*
S
% * A %2 a l ; )
# =7 a n %=- "
# • ( %D * % %& *
a
? 7 2 U%
7 n%
. "= : 8 L g y
>,B* 9 : =
,B=*
>
%=9 C= i7 )
Inter-Assay
Variation
(
g ;
V %=
82 / 1
%
6 / 1
% % # E BO 74
/ 1 % 19 / 1 %
HDL
% 15 / 2 % 28 / 1 % . >i
; 2
%9 =E ) 4
*
* ( %7 80 - ;H n V *
$&
.
MRI
%=B 2 =I %=7 ;* NKO 8
=7 a %=9 "=$H
%& =* 6* L7 4 5*
=/ MRI
?% H%* 4 5*
" %, ?% 9 ?%
. w37
% o * : X5*
. U = { ; "=*
MRI
7 # 7 a u- > - %, ~/i 7 A 6* "V %
. ; %& * E 6* "@%V7 7
7
l o 7
==
. %& ==*
?%==* : ==S == "E%==*MRI
2015
"
? 7 GE
"BB7 - XBO
45 / 0 3V .
) +! M =! E =H
Z
Z % 7 = (40-?%&S -: € - Y )/ % I7 r j +
( V - 150)/ % I7 r j + (% % # E BO - 110)/ % I7 r j + ( 2 - 94)/ % I7 r j +
( E *# E % - 130)/ % I7 r j
% % 9 M =! E =H
# S <
=7 a %=9 %= %& =* 6=*
? 7 : Y7%
OMRON BF500
#%=2 a "E%*
;K*%j7 .
+1 / 9 8 M =! E =H
7 a ;= ;= =/7 c=_ =7 %=9
"== % == r ==/7 c==_ ==7 == 2 "==K0
#% 7 ; %jK<
!
%9 6=* %= %=$
= =
N4
;K*%j7 .
!Q N
o # ?%7 #%B 2R u- %=9
g=V
==< r 2==* r ==2 # ==7 a 6==* ==
C ==< == % ==* r ==j : & %== 7 ==
|
%9 =* = N] =V7 = # =7 a
=* "$H ; V # 7 a 9 : 8 L
8 L
= %D =* =9 # .
=BI7 # =
8 %D
%9
%9 X5*
) 05 / 0 (P˂
;K*%j7 .
+1 / 7
# A= % 7 B=* ~E% %]7 t %
BMI
% 7
;V %]7 Z
9 :
EM
? H CM
1 9% 7 N %O 7
% . 7 a %9 ? =R EM
12 : 2 ;V H BK %- # 7 %
91 := =<
2 " % 7 f ]j .
= = 9 ; B fKR
z%j %= %= %= %= N= # 7
= S 8 9 : € - %= 7 %=]7
=< Z
% :&29 # ~E% S ; B H
BI7 r3 E N] V7 # 7 a t % c= B =
A v 9 L 7
%9 # B! ; L 7
l i7 z%=j =
b 2B ) ? H 2 (.
R %S 1 . ) , +! - % dW : /9 &!
) +! BMI
&! Z E G 7 G " #/
EM CM
~E%
#%7
Sig
EM CM
%
? *% # E
7 7 H
# 7 a > - 86
/ 0 41
/ 17 66± / 137 03
/ 19 00± / 139
%7 ;*
I 00
/ 0 68
/ 5 08± / 122 75
/ 16 33± / 140
2
# 7 a > - 96
/ 0 78
/ 9 25± / 103 96
/ 8 08± / 103
%7 ;*
I 02
/ 0 11
/ 7 33± / 96 63
/ 9 83± / 104
2 %*
# 7 a > - 99
/ 0 33
/ 64 58± / 130 59
/ 63 41± / 130
%7 ;*
I 54
/ 0 40
/ 59 91± / 118 85
/ 58 08± / 133
V
# 7 a > - 98
/ 0 93
/ 79 50± / 211 94
/ 76 08± / 212
%7 ;*
I 01
/ 0 91
/ 36 75± / 147 62
/ 75 25± / 216
: € - Y
7 * a > -
# 7 83
/ 0 62
/ 13 66± / 50 85
/ 12 50± / 49
%7 ;*
I 83
/ 0 27
/ 6 66± / 47 48
/ 12 83± / 46
% 7
# 7 a > - Z 96
/ 0 79
/ 1 46± / 3 - 77
/ 1 49± / 3 -
%7 ;*
I 00
/ 0 84
/ 2 20± / 0 - 43
/ 2 03± / 4 -
BMI
# 7 a > - 75
/ 0 27
/ 3 43± / 31 09
/ 3 86± / 31
%7 ;*
I 06
/ 0 83
/ 2 24± / 30 91
/ 2 12± / 32
# 7 a > -
# 74
/ 0 19
/ 8 90± / 75 49
/ 8 04± / 77
%7 ;*
I 15
/ 0 01
/ 7 01± / 73 86
/ 8 60± / 78
# S <
# 7 a > - 60
/ 0 47
/ 5 92± / 39 23
/ 5 76± / 38
%7 ;*
I 00
/ 0 84
/ 3 66± / 34 52
/ 3 91± / 39
R %S 2 . #/ &! b/ +H dW :
7 /F >
% 9 ) +! BMI
!)Q . AZ " 9
H9 !)Q 7 - % E G 9
R + 8 "/ > , +!
~E%
: 2
? B
%V29 # 7 a u % )
# ( Sig
F Sig
% % N 29
/
145 ±2483/75 17
/
118 ±2541/83 16
/ 0 69
/ 0 29
/ 0
: € - % % 07
/
61 ±491/75 81
/
56 ±496/00 15
/ 0 69
/ 0 86
/ 0
% %
8 9
96 /
89 ±1256/08 28
/
63 ±1297/83 61
/ 0 44
/ 0 20
/ 0
S % % 33
/
79 ±735/83 38
/
84 ±743/41 06
/ 0 80
/ 0 82
/ 0
S <
47 / 5 ±39/92 23
/ 5 ±38/76 00
/ 0 97
/ 0 60
/ 0
27 BMI / 3 ±31/43 09
/ 3 ±31/86 00
/ 0 97
/ 0 75
/ 0
Z % 7 79
/ 1 ± -3/46 77
/ 1 ±-3/49 01
/ 0 91
/ 0 96
/ 0
/
6596
R %S 3 . 7 G 9 D > 0 ! IL-6
IL1β
%$ N7 !
# 7 a > -
# 7 a u- sig
EM 59 IL-6
/ 1 07± / 4 88 / 0 23± / 3 00 / 0
*
59 IL1β / 1 37± / 4 88 / 0 39± / 3 00 /
*0
CM 88 IL-6
/ 1 08± / 4 48 / 1 40± / 4 07 /
*0
77 IL1β / 1 42± / 4 68 / 1 62± / 4 10 /
*0
DH %7a # 7 a t % 8 %D
=BI7
>9% # 7
IL-6
: 2 IL1β
#%
BI7 8 %D ; %@
# 7
IL-6
u-IL1β
#% %7 ;*
) ? H 3 .(
R %S 4 . 0 ! 7 G " #/ &!
IL1β ) YAIL-6
E !
EM CM
sig
IL-6 07
/ 1 23± / 3 48 / 1 40± / 4 03
/ 0 8
68 IL1β / 1 62± / 4 88 / 0 39± / 3 03
/ 0 8
V7 %7a # 7 a t % N]
#%
=B9 8 %=D
==BI7
# ==7 a u==- %==]7
IL-6
== IL1β
7
% ) ? H 4 .(
R %S 5 . 0 ! B 7 G 9 D > 0 ! E G
EM
CM
L7 4 5*
; @ 7 ]7
) mm2 ( sig
?% H%* EM
# 7 a > - 20
/ 662 27± / 14681 20
/ 0
# 7 a u- 85
/ 858 63± / 14836
?%
# 7 a > - 93
/ 529 27± / 11657 25
/ 0
# 7 a u- 18
/ 508 27± / 11721
?% 9
# 7 a > - 48
/ 1228 45± / 15602 46
/ 0
# 7 a u- 69
/ 1179 27± / 15519
?% H%* CM
# 7 a > - 28
/ 809 63± / 14800 49
/ 0
# 7 a u- 55
/ 757 27± / 14762
?%
# 7 a > - 85
/ 673 27± / 11914 30
/ 0
# 7 a u- 05
/ 638 81± / 11865
?% 9
# 7 a > - 40
/ 1151 36± / 15647 23
/ 0
# 7 a u- 77
/ 1122 90± / 15520
8 %D DH %7a # 7 a t % =BI7
#% 9 L7 4 5*
) ? H 5 .(
t % 7a # 7 a 8 %=D N] =V7 % =BI7
= #%= ? = B : 2 %7 ;* u- ) ? H 6 .(
R %S 6 . 0 ! B %&! 7 G " #/ &!
E ! ) YA
?% H%*
?%
?% 9
85 EM / 858 63± / 14836 18 / 508 27± / 11721 69 / 1179 27± / 15519
55 CM / 757 27± / 14762 05 / 638 81± / 11865 77 / 1122 90± / 15520
83 sig / 0 56
/ 0 99
/ 0
^=
6 +H G
8 = %= =9 : =2 ; D9 f ]j : === >9%=== g===H 7 6===* 7 130
;===
118
V 211
; 147 ?%&S - : € - Y 50
;==
47 ==2 103
;==
96 : ==B`29
>9%==
# E %==
137 ;==
122 :== ;== == g==H 7
?%=&S - : € - =Y = # 7 >9% 8 L BI7 K
. %]7 >9%
V 2
# E % BI7 7 % ) 05 / 0
˂ (P
. %= 7 J 2,7
~E%== Z
%==9 A== % 7 B==*
46 / 3 - ;==
20 / 0 -
>
BI7 " %
) 05 / 0
˂ ( P
; = > = :
y K$
" I
~E%
%9 =7 A % 7 B*
= %
#%
01 = 6=* 7 8 = %= 9 : 2 %7 ;*
% 7 J 2,7 ~E%= Z
%=9 "=* A= % 7 B=*
.
fKR
*
%9 # = S < # 7 ;
BMI
: " 8 <
%9 L 7 ;=* =9 : =2 =0
9%7 ; BI7 >9%
B % ) 05 / 0
˂ .(P
g=H 7 6=* 7 8 = % 9 : 2 %7 ;* %,
>9%
BI7
IL1β
) IL-6
05 / 0
˂ (P
t %= :=
t % % 8%I %57 E )
23 22 ( 7 V29 "= ! ; %
%$ > - N7 ! >9%
01 < >9% l
=2 >9%= # = S > = : = Y BMI
===7 B ===V " ===*%V@ : ===Y a ===B
bV % 7
%9 0s7 l ; * ; .%$ >9% &
2! K$
? *
%9 7 ?% a = %
. = ;=H % ;=
%V %I ; B
? * %=9 ?% = „U%=2 @
;= =,B7
: B
7 %9 .%=$ #%K=VS ? 7
- b}B7 " %I
U =R 8 =7 > = g=H 7
a V
"
> f R a
b
%9 = a
=V
7 . : 2
; R f= R b ] V7 >9%=
; ==M! ==Y a "== % : % %==* ==
? ==*
%==9
A ; =V9 ;=
=R b ] =V7 _ > = ; =* ;=
>9%= ?% = = 2! > B V " *%V@
%=$ > - N7 ! >9% 8%KH 7 # # =7
=
) 24 ( . ?%==@
;==H %==
==BI7 >9%== ;==
# == 7
V 2 # E %=
# = S =<
6=* 7 8 = %= =9 : =2 %=7 ;=* u-BMI
7 ;= %=$ N7 ! >9% " ! # 01=
%=7 ;=*
# == 7 >9%== : ==2
==
==V ==2
# E % # S <
6 BMI
.
B ==*
u
==
# %== 29 : ==2 %==7 ;==* u==-
L v 9 7%] * BI7
X5=* # 7
7 *
IL-6 hs-CRP
9% 7 # 7 ; K
TNF
; % >9%
>9% # 7 : =BI7
=K ) 14 ( . %=
;H =7 f= ]j N=<%@ 8%!3R ; =! := # =
U% ; >9%
#
# E % 140 V
230
2 6 / 109 6 g= ; 7 : ; %@
8 = %= =9 : =2 %7 ;* u- y%@ f ]j 6* 7 122 147 96 ;= "K=V = %=]7 :
==BI7 >9%== # ==7 a > ==- B ==
) 05 / 0
˂ (P
.
: B`29 #%=7 8 =7 ;= := ; ;H %
# = : =2
f ]j # "@ * "O ;K*%j7 B =*
u
# %= 29 16
;=] O : =2 8 =7 := =
N %]7 #%7 8 7 b= % =V =y%@ f= ]j B 2 7
7 7 % ;= %$ N7 ! >9% ! " ! #
"KV #a .
%=7 ;=* u- # % 29 : VB V : =2
%=$ N=7 ! # = 7 = L v =9 7%] *
IL-6
9% 7 .
# c=7 ;=I %57 100
;=
97
==2 104
;==
8 / 98 #%==7 == ;== % >9%==
& E 24
%=, =B 2 ;V H : Ea u- "!%*
) 15 ( . =! "= ! >9%=
%= >9 |=- IL-6
„U%2 @ 7 ;= A= & =E #%=7 ;= # =
"V ^ 7 B 2 ;V H : Ea .
n%=* = ;= =S
=E #%=7 ; = c 8%I %57 rc=@ = . = 57 &
N7 ! c 01 %=$ %9 % 4 5*
3 %=
4
=7 =B 2 ;V H : Ea I = %
) 25 ( . f= ]j
== ==y%@
==BI7 >9%== == %== f== ]j ; %== 7
~E%
%9 =H 2 # # A % 7 "=
) 05 / 0
˂ (P
.
& E 4
%=, Ea ;V H u-
. : B >9% 8 %D # % c 6
;= "KV
: VB V ;I %57
# % 29 . 57 %7 ; <% ;
& E
^ 7
"V .
# %= 29 =BI7 = L
N=7 ! # = 7
= 9%= 7 7%] =* : 2 %7 ;* u- %$
) 16 ( . =7 t %= i29 ! " ! #%=V ;= # =
N=7 ! @ =* 4 5=* %2 # K :=* %=$
7 a
%9 6 .
;H % =BB " = ; B ;
f ]j # % 29
# = 7 = %= Q%=S
; IL-6
R # 7 a > - 6* 7 9
/ 0 = l
B=* ;= 3 =K7 ;= =BB " ]7 : y%@ f ]j A % 7 07
/ 4 7
% . : B`29
B* : & % 7 7 a
%9 # %= 29
16 : & %= 7
y%@ f ]j B*
58 ?%*
7
% .
t %==
# %== 29 ==* f== ]j )
17 ( ==*
# %== 29 )
1 ( ==i29 ==y%@ f== ]j t %== %==
.
%== 29 ==*
# == : ==2 0s==7
>9%==
B* ; 3 K7 .%$
B =V A= % 7 )
17 (
r ==R ==&
# %== 29 …%==
) 26 (
==
==* %
# % 29 ) 27 (
>9%
hs-CRP
= 2 l IL-6
.
7 : { N %O ; %=7 f ]j #%V t % ; %
]7 =9 %= ;= D9 9 U% 8 % : 2 ?%* A N %
/
6796
;V H 60 = ;] O %=@
;=
=9%7 ;=* : =2
;
f ]j ;=V H 9 ;V H ;* ; D9 9 y%@
„%=K ]
==Ea %==7 45
%== ;==] O 57
== ;==] O )
27 26 ( .
" !
%9
&
N=7 ! >9%
%=$
=y%@ f= ]j
7 # >9%
2 % BMI
.
# % 29 * !
01=
10 = "= %I
! # == 7 == == 7 %==$† %==$ N==7
== 2
) 05 / 0
˂ (P
) 1 ( . =7 #a =B9 #% 8 9% 7 : = %
#%7 8 7 ; : 2
%=$ N=7 ! >9%= = = %
% .
! " ! t % i29
„U%=2 @ 8 %=D
#%==7 : ==2 8 ==7
;== 2
==
==7
== % . ==*
==B 2 ;==V H : ==Ea ==I ; ==<% 3 # %== 29
; 2 =y%@ f= ]j N=m7 %=$ a ; B
%$S u-
; 2 7
H ?%2 @ :
, % ; "
#%V29 l
7 .
y%@ f ]j %=7 ;=* u=- =L7 4 5* %]7
8 %D 6* 7 8 % 9 : 2 BI7
%]7 %
"== # ==7 a > ==- .
; ==<%@ t %==
%]7
;==V : ==
8 %D %7 ;* I 9 BI7
= #%
.
t % ; ;H % 7
8 %D ! " ! # „U%=2 @
%=
: 2 ; ;=,
#%=7 = = L := # =
% 8U j .
; S =2 %*
=]7 # =E =
%]7 U% B9
% I7 % 7
=DB7 B9 Z
7 b}B=7 8%=B 2 %, ; "V9 #a %} %
;7 ;=y %! N=7% o= g=H 7 8%=B 2 B=*
7 > A % 7 %
"j L7 b,@ % Z
01
O . t %== %== ==y%@ f== ]j t %==
2 ==7 ;==I %57
# % 29 ) 19 ( t % % i29 ;I %57
# V
# % 29 ) 18 ( i29 .
2 7
# % 29 E ;I %57
;= 2 %
40 ; D9
% - v 9
01 L7 b,@
:=V7 = "
) 19 ( . " !
! t %= =i29 # = 8 %=D 7
: 2 8 7
% .
A= ;= = #%= # % 29 # V : B`29 = %= %= ;=* ;= D9 9 9 : 2 ?%*
6=* 7 8
=7 L7 b,@ > gH 7 =
) 18 ( . b=,@ > =
^%K L7 > %
Vo2max
: =B`29 > =
X5*
= 2 = {BDNF
. # = 7 32 BDNF
/ 21 ;=
77 / 23 ; " % L
#%
B9 01 BI7 : 2
A
; %*
# 7 7BDNF
% ) 9 ( .
;H % ;=
;= B
% 7 ]7 B9 : =2 %=7 ;=* u=-Z
;=
E . 57 X5*
; &
; H ?%2 @ :
;7 X5=* >9%= gH 7 8%B 2 > = =
% 7 . Z
>9%= g=H 7 ;=9%7 ;=* : 2 ; B %
]7 : # S <
=@ U% % V
7 . 57 g=H 7 #a ;=7 8%=B 2 %=, ;= %
:= : } % 9 E # S < >9%
# 7 % U% # S < ;S 9 ; g 57 4 5*
9 E U% %$ N7 ! N7 ! 4 5* # U%
%$
#%= >9% gH 7 = =9 EBDNF
) 9,10 ( .
#a 4 5=* # U% ; # E S <
01=
# 7 DB7 u=- f ]j : 9 BDNF
]7 B9 9 : 2 %7 ;*
U% #%
. ;=H %=
=H ?%=2 @ := S < 9% ; ; 6 = =K$ gH 7 8%B 2 ;7 ;=,
>
L7 4 5* > BDNF
.
H 9 %U Z_>
%2 7 a
%9 " f ]j : ; %K R ;
= B = j7 "*% : B`29 =7 $= %
# %m
#%, #% *
;
%, %7 % f ]j :
7 ; %2 2< 2 b %2
.
References
1. Silva SGd, Simões PSR, Mortara RA, Scorza FA, Cavalheiro EA, Naffah- Mazzacoratti MdG, et al. Exercise-induced hippocampal anti-inflammatory response in aged rats. JNI. 2013; 10: 61-66.
2. Cavalieri M, Ropele S, Petrovic K, Pluta- Fuerst A, Homayoon N, Enzinger C, et al.
Metabolic syndrome, brain magnetic resonance imaging, and cognition. Diabetes Care. 2010; 33(12): 2489-2495.
3. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al.
Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation.
2005; 112: 2735-2752.
4. Bullo M, Peeraully MR, Trayhurn P, Folch J, Salas-Salvado J. Circulating nerve growth factor levels in relation to obesity and the metabolic syndrome in women. J Endocrinol. 2007; 157(3): 303-310.
5. Devaraj S, Torok N, Dasu MR, Samols D, Jialal I. Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop. Arterioscler Thromb Vasc Biol. 2008; 28(7): 1368-1374.
6. Rader DJ. Inflammatory markers of coronary risk. N Engl J Med. 2000; 343:
1179-1182.
7. Phillips C, Baktir MA, Srivatsan M, Salehi A. Neuroprotective effects of physical activity on the brain: a closer look at trophic factor signaling. CNS. 2014; 8: 1-16.
8. Patanella AK, Zinno M, Quaranta D, Nociti V, Frisullo G, Gainotti G, et al. Correlations Between Peripheral Blood Mononuclear Cell Production of BDNF, TNF-alpha, IL-6, IL-10 and Cognitive Performances in Multiple Sclerosis Patients. JNSR. 2010;
88: 1106-1112.
9. Tanaka S, Ide M, Shibutani T, Ohtaki H, Numazawa S, Shioda S, et al.
Lipopolysaccharide induced microglial activation induces learning and memory deficits without neuronal cell death. JNSR.
2006; 83: 557-566.
10.Yaffe K, Lindquist K, Penninx BW, Simonsick EM, Pahor M, Kritchevsky S, et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology. 2003; 61: 76-80.
11.Christos Kasapis M. The Effects of Physical Activity on Serum C-Reactive Protein and Inflammatory Markers. JACC. 2005;
45(10): 1563-1569.
12.Meek TH, Wisse BE, Thaler JP, Guyenet SJ, Matsen ME, Fischer JD, et al. BDNF action in the brain attenuates diabetic hyperglycemia via insulin-independent inhibition of hepatic glucose production.
Diabetes. 2013; 62(5): 1512-1518.
13.Brown JP, Sollers JJ, Thayer JF, Zonderman AB, Waldstein SR. Blood pressure reactivity and cognitive function in the Baltimore Longitudinal Study of Aging.
Health Psychol. 2009; 28(5): 641-646.
14.Stensvold D, Stig Arild Slørdahl MD, Wisløff U. Effect of Exercise Training on Inflammation Status Among People with
/
6996
Metabolic Syndrome. MSD. 2012; 10: 267- 272.
15.Christiansen T, Paulsen SK, Bruun JM, Pedersen SB, Richelsen B. Exercise training versus diet-induced weight-loss on metabolic risk factors and inflammatory markers in obese subjects: a 12-week randomized intervention study. AJPEM.
2010; 298(4): 824-831.
16.Lee SS, Yoo JH, Kang S, Woo JH, Shin KO, Kim KB, et al. The Effects of 12 Weeks Regular Aerobic Exercise on Brain- derived Neurotrophic Factor and Inflammatory Factors in Juvenile Obesity and Type 2 Diabetes Mellitus. J Phys Ther Sci. 2014; 26(8): 1199-1204.
17.Troseid M, Lappegard KT, Mollnes TE, Arnesen H, Seljeflot I. The effect of exercise on serum levels of interleukin-18 and components of the metabolic syndrome.
MSD. 2009; 70: 579-584.
18.Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L, et al. Exercise training increases size of hippocampus and improves memory. PNAS. 2011; 108(7):
3017-3022.
19.Mortimer JA, Ding D, Borenstein AR, DeCarli C, Guo Q, Wu Y, et al. Changes in brain volume and cognition in a randomized trial of exercise and social interaction in a community-based sample of non-demented Chinese elders. J Alzheimers Dis. 2012;
30(4): 757-766.
20.Babaei P, damirchi A, Alamdari KA.
Effects of Endurance Training and Detraining on Serum BDNF and Memory Performance in Middle Aged Males with
Metabolic Syndrome. IJEM. 2013; 15(2):
132-142. (In Persian)
21.Qi Z, He J, Zhang Y, Shao Y, Ding S.
Exercise training attenuates oxidative stress and decreases p53 protein content in skeletal muscle of type 2 diabetic Goto- Kakizaki rats. FRBM. 2011; 50(7): 794- 800.
22.Esposito K, Pontillo A, DiPalo C, Giugliano G, Masella M, Marfella R, et al. Effect of weight loss and life style changes on vascular inflammatory markers in obese women: a randomized trial. JAMA. 2003;
289: 1799-1804.
23.Gielen S, Adams V, Möbius-Winkler S, Linke A, Erbs S, Yu J, et al. Anti- inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol. 2003; 42:
861-868.
24.Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P, et al.
Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity. 1997; 6: 315-325.
25.Shayan A, Bagherzadeh F, Shahbazi M, Choobineh S. The Effect of Two Types of Exercise (Endurance and Resistance) on Attention and Brain Derived Neurotropic Factor Levels in Sedentary Students. JDML.
2015; 6(4): 433-452. (In Persian)
26.Oberbach A, Lehmann S, Kirsch K, Krist J, Sonnabend M, Linke A, et al. Long-term exercise training decreases interleukin-6 (IL-6) serum levels in subjects with impaired glucose tolerance: effect of the
K174G/C variant in IL-6 gene. EJE. 2008;
159: 129-136.
27.Balducci S, Zanuso S, Nicolucci A, Fernando F, Cavallo S, Cardelli P, et al.
Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. NMCD. 2010; 20: 608-617.
/
7196
The Effect of Three -Month Aerobic Exercise with Moderate Intensity on IL1β, IL-6, and brain volume in 50-65 Years Old Women with Metabolic Syndrome
Osali A*1, Choobineh S2, Soori R2, Ravasi AA3, Mostafavi H4
1. PhD of Sport Physiology, Department of Physical Education and Sport Sciences, Faculty of Physical Education , Tehran University, Tehran, [email protected].
2. Associate Professor, Department of Physical Education and Sport Sciences, Faculty of Physical Education, Tehran University, Tehran, Iran.
3. Professor, Department of Physical Education and Sport Sciences, Faculty of Physical Education, Tehran University, Tehran, Iran.
4. Assistant Professor, Department of Neurophysiology, Zanjan University of Medical Sciences, Zanjan, Iran.
Received: 28 March 2017 Accepted: 27 May 2017
Abstract
Background: The increasing of age, inflammatory factors¸ and metabolic syndrome are the effective reasons in the reduction of brain volume. The aim of this research was to investigate the effect of twelve week aerobic exercise with moderate intensity on IL1β, IL-6, and brain volume in 50-65 years old women with metabolic syndrome.
Materials and Methods: 24 women with Metabolic Syndrome (MetS) took a part voluntarily.
They were divided into two groups, MetS exercise (EM), MetS control (CM). ME group participated in an aerobic exercise training (AT) program (for 12 weeks), three sessions per week, each session contained three performing parts and two relaxing parts, at the beginning, each part contained eight minutes. Also each week, one minute added to performing sets. MRI and blood samples were conducted before and after three month to evaluate the levels of IL1β, IL-6, and brain volume. Data were analyzed by paired-sample of T-Test, and independent samples of T-Test.
Results:Brain volume afterthree month doesn't significantly changed, but IL1β, and IL-6 after tree month exercise were significantly decreased (P<0.05). Also, there were not significantly different in brain volume, IL1β, and IL-6 pre and post test in the control group.
Conclusion: These findings indicate that three months aerobic exercise with a moderate intensity ameliorate inflammatory factor and doesn't change brain volume. Maybe with adjusting, the time and intensity of exercise brain volume will be increased.
Keywords:Aerobic exercise, IL1β, IL-6, Brain volume, Metabolic syndrome.
*Citation: Osali A, Choobineh S, Soori R, Ravasi AA, Mostafavi H. The Effect of Three -Month Aerobic Exercise with Moderate Intensity on IL1β, IL-6, and brain volume in 50-65 Years Old Women with Metabolic Syndrome. Yafte. 2017;
19(2): 60-71.
